Activation of b-lymphocytes during pollen season. Effect of immunotherapy

Clinical and Experimental Allergy

Volumn 28, Issue 7, 1998, Pages 791-798

  Hakansson L ^a   Heinrich, C ^b   Rak, S ^c   Venge, P ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b CENTRAL HOSPITAL   (Sweden)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

B lymphocyte; CD23; CD40; HLA DR; Immunotherapy; Pollen season

Indexed keywords

POLLEN ANTIGEN;

ARTICLE; B LYMPHOCYTE; IMMUNOTHERAPY; LYMPHOCYTE ACTIVATION; POLLEN ALLERGY; PRIORITY JOURNAL; SEASONAL VARIATION;

ADULT; ALLERGENS; ANTIGENS, CD19; ANTIGENS, CD40; ASTHMA; B-LYMPHOCYTES; CELL COUNT; DOUBLE-BLIND METHOD; FEMALE; FLOW CYTOMETRY; HLA-DR ANTIGENS; HUMANS; HYPERSENSITIVITY; IMMUNOTHERAPY; LYMPHOCYTE ACTIVATION; MALE; METHACHOLINE CHLORIDE; MIDDLE AGED; POLLEN; RECEPTORS, IGE; SEASONS; TREES;

EID: 0031865216     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.1998.00295.x     Document Type: Article

References (33)

1. Spiegelberg HL. CD 23. A novel multifunctional regulator of the immune system that binds IgE. Fc∈R2/CD23: Its discovery and possible functions. Monogr Allergy 1991; 29:1-8.
2. Conrad DH. Fc∈RII/CD23: The low affinity receptor for IgE. Annu Rev Immunol 1990; 8:623-45.
3. Banchereau J, Rousset F. Human B. lymphocytes. Phenotype, proliferation, and differentiation. In: Dixon FJ., ed. Advances in Immunology, New York: Academic Press, Inc. 1992:125-264.
4. Bonnefoy JY, Plater-Zyberk C, Lecoanet-Henchoz S, Gauchat JF, Aubry JP, Graber P. A new role for CD23 in inflammation. Immunol Today 1996; 17:418-20.
5. van der Heijden FL, van Neerven RJJ, van Katwijk M, Bos JD, Kapsenberg ML. Serum-IgE-facilitated allergen presentation in atopic disease. J Immunol 1993; 150:3643-50.
6. Gustavsson S, Hjulström S, Tianmin L, Heyman B. CD 23/IgE-mediated regulation of the specific antibody response in vivo. J Immunol 1994; 152:4793-800.
7. Bonnefoy JY, Guillot O, Spits H, Blanchard D, Ishizaka K, Banchereau J. The low-affinitiy receptor for IgE (CD23) on B lymphocytes is spatially associated with HLA-DR antigens. J Exp Med 1988; 167:57-72.
8. Flores-Romo L, Johnson GG, Ghaderi AA, Stanworth DR, Veronesi A, Gordin J. Functional implication for the topographical relationship between MHC class II and the low-affinity IgE receptor: occupancy of CD23 prevents B lymphocytes from stimulating allogeneic mixed lymphocyte responses. Eur J Immunol 1990; 20:2465-9.
9. Splawski JB, Fu SM, Lipsky PE. Immunoregulatory role of CD40 in human B cell differentiation. J Immunol 1993; 150:1276-85.
10. Nonoyama S, Hollenbaugh D, Aruffo A, Ledbetter JA, Ochs HDB. cell activation via CD40 is required for specific antibody production by antigen-stimulated human B cells. J Exp Med 1993; 178:1097-102.
11. Durie FH, Foy TM, Masters SR, Laman JD, Noelle RJ. The role of CD40 in the regulation of humoral and cell-mediated immunity. Immunol Today 1994; 15:406-11.
12. Gagro A, Rabatic S, Trescec A, Dekaris D, Medar-Lasic M. Expression of lymphocytes Fc∈RII, /CD. 23 in allergic children undergoing hyposensitization. Int Arch Allergy Immunol 1993; 101:203-8.
13. Corominas M, Mestre M, Bas J et al. CD23 expression on B-lymphocytes and its modulation by cytokines in allergic patients. Clin Exp Allergy 1993; 23:612-7.
14. Jung CM, Prinz JC, Rieber EP, Ring JA. Reduction in allergen-induced FcR2/CD23 expression on peripheral B-cells correlates with successful hyposensitization in grass pollinosis. J Allergy Clin Immunol 1995; 95:77-87.
15. Nakagawa T, Gershwin ME. Immunotherapy of allergic diseases. Int Arch Allergy Immunol 1993; 102:117-20.
16. Norman PS. Modern concepts of immunotherapy. Curr Opin Immunol 1993; 5:968-73.
17. Daëron M, Latour S, Malbec O et al. The same tyrosine-based inhibition motif, in the intracytoplasmic domain of FcγRIIB, regulates negatively BCR, TCR, and FcR-dependent cell activation. Immunity 1995; 3:635-16.
18. Löwhagen O, Lindholm NB. Short-term and long-term variation in bronchial response to histamine in asthmatic patients. Eur J Respir Dis 1983; 64:466-72.
19. Ogden EC, Raynor GS, Hayes JV, Lewis DM, Haines JH. Manual for sampling airborne pollen, New York: Hafner Press, 1974.
20. Carlson M, Håkansson L, Kämpe M, Stålenheim G, Peterson C, Venge P. Degranulation of eosinophils from pollen atopic patients is increased during pollen season. J Allergy Clin Immunol 1992; 89:131-9.
21. Gagro A, Rabatic S, Lokar-Kolbas R, Medar-Lasic M, Zimic L. Effect of an asthmatic attack on CD23 and CD21 expression on lymphocytes from allergic children during the allergen season. Clin Exp Allergy 1995; 25:690-7.
22. Zurawski G, De Vries JE. Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunol Today 1994; 15:19-26.
23. Koike M, Takatsu KIL. -5 and its receptor: Which role do they play in the immune response. Int Arch Allergy Immunol 1994; 104:1-9.
24. Punnonen J, Aversa G, Cocks BG et al. Interleukin 13 induces interelukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B-cells. Proc Natl Acad Sci USA 1993; 90:3730-4.
25. Fujiwara H, Kikutani H, Suematsu S et al. The absence of IgE antibody-mediated augmentation of immune responses in CD23-deficient mice. Proc Natl Acad Sci USA 1994; 91:6835-9.
26. Kehry MR, Yamashita LC. Low-affinity IgE, receptor (CD. 23) function on mouse B cells: Role in IgE-dependent antigen focusing. Proc Natl Acad Sci USA 1989; 86:7556-60.
27. Peng Z, Naclerio RM, Norman PS, Adkinson NF Jr. Quantitative IgE-, IgG. -subclass responses during and after long-term ragweed immunotherapy. J Allergy Clin Immunol 1992; 89:519-29.
28. Varney VA, Hamid QA, Gaga M et al. Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses. J Clin Invest 1993; 92:644-51.
29. McHugh SM, Deighton J, Stewart AG, Lachmann PJ, Ewan PW. Bee venom immunotherapy induces a shift in cytokine responses from a TH-2 to a TH-1 dominant pattern: Comparison of rush and conventional immunotherapy. Clin Exp Allergy 1995; 25:828-38.
30. Håkansson L, Heinrich C, Rak S, Venge P. Priming of eosinophil adhesion in birch pollen allergic patients during pollen season. Effect immunotherapy J Allergy Clin Immunol 1997; 99:551-62.
31. Abramson MJ, Puy RM, Weiner JM. Is allergen immunotherapy effective in asthma? A meta-analysis of randomized controlled trials. Am J Respir Crit Care Med 1995; 151:969-74.
32. Woschnagg C, Rak S, Venge P. Oxygen radical production by blood eosinophils is reduced during birch pollen season in allergic patients. Clin Exp Allergy 1996; 26:1064-72.
33. Venge P, Roxin L-E, Olsson I. Radioimmunoassay of human eosinophil cationic protein. Br J Haematol 1977; 37:331-5.